Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin receptor antagonism for treatment of insomnia
W. Joseph Herring, Ellen Snyder, Kerry Budd, et al.
Neurology (2012) Vol. 79, Iss. 23, pp. 2265-2274
Closed Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline
Michael J. Sateia, Daniel J. Buysse, Andrew D. Krystal, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 02, pp. 307-349
Open Access | Times Cited: 1162
Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
Hong Fang, Sheng Tu, Jifang Sheng, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 4, pp. 2324-2332
Open Access | Times Cited: 775
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson, Ellen Snyder, Erin M. Paradis, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 5, pp. 461-471
Closed Access | Times Cited: 480
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Jennifer Schroeck, James M. Ford, Erin Conway, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 11, pp. 2340-2372
Open Access | Times Cited: 308
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May, et al.
Biological Psychiatry (2014) Vol. 79, Iss. 2, pp. 136-148
Closed Access | Times Cited: 257
Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Leslie Citrome
International Journal of Clinical Practice (2014) Vol. 68, Iss. 12, pp. 1429-1441
Open Access | Times Cited: 246
The hypocretins/orexins: integrators of multiple physiological functions
Jingcheng Li, Zhian Hu, Luı́s de Lecea
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 332-350
Open Access | Times Cited: 229
The neurobiological basis of narcolepsy
Carrie E. Mahoney, Andrew C. Cogswell, Igor J. Koralnik, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 2, pp. 83-93
Open Access | Times Cited: 216
New therapeutic approaches for the prevention and treatment of migraine
Hans‐Christoph Diener, Andrew Charles, Peter J. Goadsby, et al.
The Lancet Neurology (2015) Vol. 14, Iss. 10, pp. 1010-1022
Closed Access | Times Cited: 179
The assessment and management of insomnia: an update
Andrew D. Krystal, Aric A. Prather, Liza H. Ashbrook
World Psychiatry (2019) Vol. 18, Iss. 3, pp. 337-352
Open Access | Times Cited: 177
Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies
Danielle K. Sandsmark, Jonathan E. Elliott, Miranda M. Lim
SLEEP (2017)
Open Access | Times Cited: 172
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 541-551
Open Access | Times Cited: 138
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis
Jing-Li Yue, Xiang-Wen Chang, Jun-Wei Zheng, et al.
Sleep Medicine Reviews (2023) Vol. 68, pp. 101746-101746
Closed Access | Times Cited: 49
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men
Hong Sun, William P. Kennedy, Darren Wilbraham, et al.
SLEEP (2013)
Open Access | Times Cited: 149
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Christopher J. Winrow, John J. Renger
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 283-293
Open Access | Times Cited: 144
Advances in the management of chronic insomnia
Margaret Kay-Stacey, Hrayr Attarian
BMJ (2016), pp. i2123-i2123
Closed Access | Times Cited: 144
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Akira Kuriyama, Hiromitsu Tabata
Sleep Medicine Reviews (2016) Vol. 35, pp. 1-7
Closed Access | Times Cited: 133
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Kärppä, Jane Yardley, Kate Pinner, et al.
SLEEP (2020) Vol. 43, Iss. 9
Open Access | Times Cited: 127
Sleep disorders, obesity, and aging: The role of orexin
Joshua P. Nixon, Vijayakumar Mavanji, Tammy A. Butterick, et al.
Ageing Research Reviews (2014) Vol. 20, pp. 63-73
Open Access | Times Cited: 120
Insomnia: Pharmacologic Therapy.
Eric M. Matheson, B L Hainer
PubMed (2017) Vol. 96, Iss. 1, pp. 29-35
Closed Access | Times Cited: 116
Hypocretin (orexin) regulation of sleep-to-wake transitions
Luı́s de Lecea, Ramón Huerta
Frontiers in Pharmacology (2014) Vol. 5
Open Access | Times Cited: 108
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Page 1 - Next Page

Scroll to top